Saturday Nov 23
Wyeth India to merge with Pfizer's local unit
File photo: Jeffrey Kindler , Chairman and CEO of Pfizer, and Bernard Poussot, Chairman and CEO of Wyeth, shake hands after announcing merger of the two companies in New York, January 26, 2009.
KVA1s first steps after emerging from bankruptcy
KV Pharmaceutical has appointed two new board members to join its newly elected board chairman, Joseph Mahady, after emerging from bankruptcy in September.
KV Pharmaceutical Company Appoints Former Wyeth Pharmaceuticals...
ST. LOUIS, Oct. 3, 2013 /PRNewswire/ -- K-V Pharmaceutical Company today announced the appointment of Joseph M. Mahady as Chairman of its Board of Directors.
KV Pharmaceutical appoints new chairman
KV Pharmaceutical has appointed Joseph Mahady as its new chairman of the board. Mahady had previously served as senior vice president of Wyeth LLC and president of Wyeth's Pharmaceuticals Inc., where he led the company's $20 billion global pharmaceutical business.
Customer Interaction Solutions
Cubist Pharmaceuticals Appoints Kenneth Martin to Board of Directors
Cubist Pharmaceuticals, Inc. today announced the appointment of Kenneth J. Martin to its Board of Directors.